112
Participants
Start Date
September 30, 2006
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Infliximab
"Prior to week 26~* Infliximab 3mg/kg standard regime (weeks 0, 2, 6, 14, 22)~* Methotrexate commencing at 10mg weekly, progressing to 20mg by week 6.~* Folic acid 5 mg daily except the day methotrexate is taken~Patients will be unblinded at week 26 and then treated pragmatically guided by disease activity"
Methylprednisolone
Steroid
Methotrexate
All patients enrolled are commenced on oral methotrexate 10mg once a week The methotrexate dose should be increased to 15 mg at the week 2 visit. The methotrexate should be increased to 20mg at the week 6 visit.
Folic acid
All patients enrolled are commenced on oral folic acid 5mg daily, except the day methotrexate is taken, and the study infusions.
Chapel Allerton Hospital, Leeds
University of Leeds
OTHER